News

Which symptoms of SLE have the greatest impact on quality of life? What are the most common comorbid emotional disorders? Answers here.

Actemra can be given alone or in combination with methotrexate in patients with polyarticular juvenile idiopathic arthritis.

FDA Approves SC Formulation of Tocilizumab for Polyarticular Juvenile Idiopathic Arthritis (PJIA).

Here, insights from some experts on the patient’s experience of rheumatoid arthritis.

Lupus is not listed in national mortality rankings but appears to be the 10th leading cause of death in females aged 15-24 years. Where to go from here?

Weight loss surgery can reduce bone mass and strength and increase the risk of fractures.

The BLA was originally accepted by the FDA for review in September 2017, with the product intended to be used for the treatment of immunological conditions such as rheumatoid arthritis, as well as blood cancers.

A recent meta-analysis compared acetaminophen, cortisone injections, platelet-rich plasma, hyaluronic acid, and several NSAIDs.

The coflex Interlaminar Stabilization disposable instrument kit is a serviceable outpatient set of injection molded instruments provided in a pre-sterilized peel pack for the posterior lumbar motion preservation solution.

Both weight loss and obesity are associated with worsening disability in RA.

The challenge: to reduce the dose without an increase in patient-reported pain intensity.

An alternative to opioids is shown to be effective in patients with diabetic neuropathy, complex regional pain syndrome, and failed spine surgery.

The committee recommends the approval of baricitinib 2-mg, but not 4-mg; this comes a year after baricitinib was rejected by the FDA.

Recent studies have shed light on the pathophysiology, clinical diagnosis, and effective management of fibromyalgia. Are you up-to-date?

Researchers analyzed mortality statistics from the CDC to determine the relative burden of SLE-related deaths among women.

The American College of Rheumatology developed a formal curriculum for NPs and PAs to help swell the ranks of clinicians who provide rheumatologic care.

Researchers look deep to find the cause of synovitis and dactylitis in patients with psoriatic arthritis.

While its safety profile was lessened, celecoxib, in comparison with naproxen and ibuprofen, remained favorable when taken with aspirin.

RF positive, young with high disease activity . . . a big negative for MTX success.

Do statins increase or lower the risk of rheumatoid arthritis? Researchers sorted through a host of confounding factors to arrive at an answer.

For better or worse, social media and the Internet have a large role in the lives of young people-and as such are an effective way to reach them.

Female athletes face a higher risk of requiring additional knee surgery.

A study sheds new light on the extra-articular manifestations of spondyloarthritis-with a focus on the heart as a high-risk target.

Upadacitinib (15 mg, once-daily) met both primary endpoints, with 71% of patients achieving ACR20 and 29% achieving clinical remission at week 12.

This morning, AbbVie revealed positive top-line results from the Phase 3 SELECT-COMPARE clinical trial evaluating upadacitinib in rheumatoid arthritis.

A potential alternative to immunosuppressants for the treatment of joint inflammation in lupus.

The time to revisit treatment approaches for gout is now.

Which patients need bisphosphonate therapy-and for how long?

These strategies address critical issues that have stymied the lupus drug development process for decades.

However, researchers found that a common treatment for SLE reduces the risk of flares to that of non-pregnant women with lupus.